We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+1.85%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
–
AUM
$4.01B
AUM Growth
-$55.8M
Cap. Flow
-$77.9M
Cap. Flow %
-1.94%
Top 10 Hldgs %
16.78%
Holding
730
New
81
Increased
176
Reduced
283
Closed
57

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$32.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$28.3M
3
VZ icon
Verizon
VZ
+$26.7M
4
LOW icon
Lowe's Companies
LOW
+$25.6M
5
CMI icon
Cummins
CMI
+$20.9M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$38.5M
2
CL icon
Colgate-Palmolive
CL
+$31.6M
3
LLY icon
Eli Lilly
LLY
+$30.3M
4
HD icon
Home Depot
HD
+$28.5M
5
MSFT icon
Microsoft
MSFT
+$25.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.88%
2 Technology 13.15%
3 Financials 10.92%
4 Communication Services 10.03%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.9T
$112M 2.8%
4,688,332
-552,212
-11% -$13.7M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.08T
$88.1M 2.2%
2,504,960
-636,780
-20% -$23.4M
AMGN icon
3
Amgen
AMGN
$209B
$69M 1.72%
453,253
-3,225
-0.7% -$501K
MSFT icon
4
Microsoft
MSFT
$3.35T
$67M 1.67%
1,310,020
-482,707
-27% -$25.1M
META icon
5
Meta Platforms (Facebook)
META
$1.37T
$66.4M 1.66%
580,710
-39,258
-6% -$4.52M
UNH icon
6
UnitedHealth
UNH
$383B
$62M 1.55%
439,315
-2,151
-0.5% -$287K
GILD icon
7
Gilead Sciences
GILD
$163B
$60.8M 1.52%
729,102
-9,549
-1% -$847K
CMCSA icon
8
Comcast
CMCSA
$84B
$53M 1.32%
1,626,918
-283,678
-15% -$8.81M
XOM icon
9
ExxonMobil
XOM
$651B
$48.3M 1.21%
515,773
-95,680
-16% -$8.46M
DIS icon
10
Walt Disney
DIS
$167B
$46M 1.15%
470,294
-135,984
-22% -$13.6M
BR icon
11
Broadridge
BR
$17.9B
$44.4M 1.11%
680,764
-2,058
-0.3% -$127K
CVS icon
12
CVS Health
CVS
$134B
$42.7M 1.07%
446,163
+28,096
+7% +$2.8M
BMY icon
13
Bristol-Myers Squibb
BMY
$132B
$41.3M 1.03%
561,927
+400,099
+247% +$28.3M
JNJ icon
14
Johnson & Johnson
JNJ
$617B
$38.8M 0.97%
319,741
+1,182
+0.4% +$134K
NOC icon
15
Northrop Grumman
NOC
$76B
$38.3M 0.96%
172,333
-3,086
-2% -$650K
V icon
16
Visa
V
$684B
$38.2M 0.95%
515,411
-2,425
-0.5% -$190K
AMZN icon
17
Amazon
AMZN
$2.53T
$37.7M 0.94%
1,053,820
+2,080
+0.2% +$70.4K
JPM icon
18
JPMorgan Chase
JPM
$933B
$36.3M 0.91%
584,934
-16,612
-3% -$1.04M
LLL
19
DELISTED
L3 Technologies, Inc.
LLL
$36M 0.9%
245,139
+19,715
+9% +$2.65M
VZ icon
20
Verizon
VZ
$193B
$35.7M 0.89%
639,098
+513,929
+411% +$26.7M
ETN icon
21
Eaton
ETN
$150B
$34.1M 0.85%
571,639
+41,073
+8% +$2.52M
KDP icon
22
Keurig Dr Pepper
KDP
$43B
$32.7M 0.81%
338,064
-91,512
-21% -$8.4M
CELG
23
DELISTED
Celgene Corp
CELG
$31.7M 0.79%
320,977
-8,170
-2% -$845K
HD icon
24
Home Depot
HD
$332B
$31.6M 0.79%
247,709
-215,165
-46% -$28.5M
LOW icon
25
Lowe's Companies
LOW
$118B
$31.1M 0.78%
393,423
+331,216
+532% +$25.6M
1
2 3 4 5

Similar funds

GVI
Green Valley Investors Wilmington, Delaware $1.76B AUM 5.64% 1-Year Est. Return
GMI
Greystone Managed Investments Regina, Saskatchewan, Canada $1.65B AUM 7.9% 1-Year Est. Return
CA
Cortland Advisers Wilmington, Delaware $2.18B AUM 8.82% 1-Year Est. Return
AWM
Ashmore Wealth Management Wilmington, Delaware $1.58B AUM 9.28% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
STMM
South Texas Money Management San Antonio, Texas $2.37B AUM 5.24% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Boston Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Boston Advisors held 730 positions worth $4.01B, down 1.4% from $4.06B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Advisors's Q2 2016 filing shows 81 new, 176 increased, 283 reduced and 57 closed positions. Its largest new stake was Sherwin-Williams: 204,480 shares worth $20M. The largest sale was AbbVie, an estimated $38.5M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q2 2016 buy was Sherwin-Williams: 204,480 shares worth $20M.
  • Boston Advisors added most to Biogen in Q2 2016, an estimated $32.1M increase.
  • Boston Advisors's biggest Q2 2016 reduction was AbbVie, cutting an estimated $38.5M.
  • Boston Advisors fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $23.4M.
  • Boston Advisors's ten largest holdings make up 17% of its $4.01B portfolio in Q2 2016.
  • Boston Advisors opened 81 new positions and closed 57 in Q2 2016.
  • Boston Advisors's portfolio value fell 1.4% quarter-over-quarter to $4.01B.

Based on Boston Advisors's 13F filing for Q2 2016, filed 26 Jul 2016.